Comparative analysis of three-year efficacy of catheter ablation of atrial fibrillation using the Ablation Index module and the second-generation cryoballoon
https://doi.org/10.35336/VA-1504
Abstract
Aim. To compare immediate and long-term outcomes of catheter-based atrial fibrillation (AF) treatment following pulmonary vein (PV) cryoballoon ablation (CBA) using the second-generation cryoballoon and PV radiofrequency ablation (RFA) performed on the navigation system using the contact force-sensing catheter with the AI module.
Methods. The study included 199 patients referred for PV isolation between 2018 and 2021. Patients were divided into two groups: the study group (n=110) underwent PV isolation via RFA using the catheter with the AI module; the control group (n=89) underwent PV CBA using the second-generation cryoballoon. The follow-up period was limited to 36 months, with a mean follow-up of 27.9 ± 14.2 months.
Results. The three-year efficacy of CBA and RFA using the AI module was comparable (freedom from atrial tachy arrhythmias: RFA group 0.61±0.05, CBA group 0.62±0.05 (Log-Rank test, p = 0.896)), with similar complication rates and profiles (3.6% (n=4) vs. 4.5% (n=4), p=0.759). The AF recurrence rate during the blanking period was significantly lower in the RFA group using the AI module (1.8% (n=2) vs. 9.0% (n=8) in the CBA group, p=0.045). Procedure duration was significantly shorter in the cryoablation group (RFA 92.7±20.9 min, CBA 83.9±19.6 min, p=0.005). The need for repeat intervention was comparable between groups (RFA 21.8% (n=24), CBA 30.3% (n=27), p=0.171).
Conclusion. Comparative analysis of the three-year efficacy of radiofrequency antral pulmonary vein isolation using the catheter with the “Ablation Index” (AI) module demonstrated results comparable to ablation with the secondgeneration cryoballoon. Furthermore, during the blanking period, the RFA group showed a statistically significant reduction in AF recurrence compared to the CBA group.
About the Authors
S. N. AzizovRussian Federation
Azizov Sardor
Perm, 35 Marshal Zhukov str.
R. D. Khuziakhmetov
Russian Federation
Perm, 35 Marshal Zhukov str.
V. V. Lyashenko
Russian Federation
Kaliningrad, 4 Kaliningradskoye Shosse
V. A. Belov
Russian Federation
Perm, 35 Marshal Zhukov str.
A. T. Kozhenov
Russian Federation
Moscow, 23 Veshnyakovskaya str.
References
1. Van Gelder IC, Rienstra M, Bunting KV, et al.; ESC Scientific Document Group. 2024 ESC Guidelines for the management of atrial fibrillation developed in collaboration with the European Association for Cardio-Thoracic Surgery (EACTS). Eur Heart J. 2024;45(36): 3314-3414. https://doi.org/10.1093/eurheartj/ehae176.
2. Squara F, Zhao A, Marijon E, et al. Comparison between radiofrequency with contact force-sensing and second-generation cryoballoon for paroxysmal atrial fibrillation catheter ablation: A multicentre european evaluation. Europace. 2015;17: 718-724. https://doi.org/10.1093/europace/euv060.
3. Jourda F, Providencia R, Marijon E, et al. Contact-force guided radiofrequency vs. Second-generation balloon cryotherapy for pulmonary vein isolation in patients with paroxysmal atrial fibrillation-a prospective evaluation. Europace. 2015;17: 225-231. https://doi.org/10.1093/europace/euu215.
4. Kuck KH, Brugada J, Furnkranz A, et al. Cryoballoon or radiofrequency ablation for paroxysmal atrial fibrillation. N Engl J Med. 2016;374: 2235-2245. https://doi.org/10.1056/NEJMoa1602014.
5. Mikhaylov EN, Gasimova NZ, Ayvazyan SA, et al. Factors associated with the efficacy of atrial fibrillation radiofrequency catheter ablation: opinion of the cialists who use the “ablation index” module. Journal of Arrhythmology. 2020;27(3): 9-24. (In Russ.). https://doi.org/10.35336/VA-2020-3-9-24.
6. Nakagawa H., Ikeda A., Govari A., et al. Prospective study to test the ability to create RF lesions at predicted depth and diameter using a new formula incorporating contact force, radiofrequency power and application time (force-power-time index) in the beating canine heart. Heart Rhythm. 2014;11: S548.
7. Das M, Loveday JJ, Wynn GJ, et al. Ablation index, a novel marker of ablation lesion quality: prediction of pulmonary vein reconnection at repeat electrophysiology study and regional differences in target values. Europace. 2017;19: 775- 83. https://doi.org/10.1093/europace/euw105.
8. Ullah W, Hunter RJ, Finlay MC, et al. Ablation Index and Surround Flow Catheter Irrigation: Impedance-Based Appraisal in Clinical Ablation. JACC Clin Electrophysiol. 2017;3(10): 1080-1088. https://doi.org/10.1016/j.jacep.2017.03.011.
9. Hussein A, Das M, Chaturvedi V, et al. Prospective use of Ablation Index targets improves clinical outcomes following ablation for atrial fibrillation. J Cardiovasc Electrophysiol. 2017;28(9): 1037- 1047. https://doi.org/10.1111/jce.13281.
10. Phlips T, Taghji P, El Haddad M, et al. Improving procedural and oneyear outcome after contact force-guided pulmonary vein isolation: the role of interlesion distance, ablation index, and contact force variability in the ’CLOSE’-protocol. Europace. 2018;20(FI_3): f419-f427. https://doi.org/10.1093/europace/eux376.
11. Solimene F, Schillaci V, Shopova G, et al. Safety and efficacy of atrial fibrillation ablation guided by ablation index module. J Interv Card Electrophysiol. 2019;54: 9-15.
12. Casella M, Dello Russo A, Riva S, et al. An ablation index operator-independent approach to improve efficacy in atrial fibrillation ablation at 24-month follow-up: a single center experience. J Interv Card Electrophysiol. 2019;57: 241-9.
13. Ioannou A, Papageorgiou N, Lim WY, et al. Efficacy and safety of ablation index-guided catheter ablation for atrial fibrillation: an updated meta-analysis. Europace. 2020;22: 1659-1671.
14. Kuck KH, Furnkranz A, Chun KR, et al. Cryoballoon or radiofrequency ablation for symptomatic paroxysmal atrial fibrillation: reintervention, rehospitalization, and quality-of-life outcomes in the FIRE AND ICE trial. European heart journal. 2016;37(38): 2858-65.
15. Chichkova T.Yu., Mamchur S.E., Ivanitsky E.A., et al. Сomparison of effectiveness of radiofrequency ablation and cryoablation of atrial fibrillation based on the experience of two clinical centers. Journal of Arrhythmology. 2017;(88): 30-35. (In Russ.).
16. Buist, TJ, Adiyaman A, Smit JJJ, et al. Arrhythmia-free survival and pulmonary vein reconnection patterns after second-generation cryoballoon and contact-force radiofrequency pulmonary vein isolation. Clin Res Cardiol. 2018;107: 498-506. https://doi.org/10.1007/s00392-018-1211-9.
17. Maskoun W, Abualsuod A, Habash F, et al. Cryoballoon vs radiofrequency ablation of atrial fibrillation: insights from the Veterans Healthcare System. J Interv Card Electrophysiol. 2021;62: 531-538. https://doi.org/10.1007/s10840-020-00927-3.
18. Matta M, Anselmino M, Ferraris F, Scaglione M, Gaita F. Cryoballoon vs. radiofrequency contact force ablation for paroxysmal atrial fibrillation: a propensity score analysis. J Cardiovasc Med (Hagerstown). 2018;19(4): 141- 147. https://doi.org/10.2459/JCM.0000000000000633.
19. Reddy VY, Sediva L, Petru J, et al. Durability of pulmonary vein isolation with cryoballoon ablation: results from the sustained PV isolation with arctic front advance (SUPIR) study. J Cardiovasc Electrophysiol. 2015;26: 493-500.
20. Aryana A, Singh SM, Mugnai G, et al. Pulmonary vein reconnection following catheter ablation of atrial fibrillation using the second-generation cryoballoon versus open-irrigated radiofrequency: results of a multicenter analysis. J Interv Card Electrophysiol. 2016;47(3): 341- 348. https://doi.org/10.1007/s10840-016-0172-z.
21. Andrade JG, Khairy P, Dubuc M. Catheter cryoablation: biology and clinical uses. Circ Arrhythm Electrophysiol. 2013;6(1): 218-27. https://doi.org/10.1161/CIRCEP.112.973651.
Review
For citations:
Azizov S.N., Khuziakhmetov R.D., Lyashenko V.V., Belov V.A., Kozhenov A.T. Comparative analysis of three-year efficacy of catheter ablation of atrial fibrillation using the Ablation Index module and the second-generation cryoballoon. Journal of Arrhythmology. 2025;32(3):37-44. (In Russ.) https://doi.org/10.35336/VA-1504